Chemours (CC) Tops Q4 EPS by 22c, Offers FY Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/16/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- SanDisk upgraded at JPMorgan after investor day; shares climb
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
The Chemours Company Reports Fourth Quarter and Full Year 2017 Results; Robust Performance Across All Segments and Key Financial Metrics
February 14, 2018 4:15 PM EST
WILMINGTON, Del., Feb. 14, 2018 /PRNewswire/ --
Fourth Quarter 2017 Highlights
Net Sales of $1.6 billion, up 19% Net Income of $228 million, up $458 million with EPS of $1.19 per diluted share, up $2.45 per diluted share Adjusted Net Income of $229 million, up $196 million with Adjusted EPS of $1.19 per diluted share, up $1.01 per diluted share Adjusted EBITDA of $394 million, up 65%Full Year 2017 Highlights
Net Sales of $6.2 billion, up 15% Net Income of $746 million, up $739 million with EPS of $3.91 per diluted share, up $3.87 per diluted share Adjusted... More